GlassScriptPhysician profile
Beau J Ellenbecker
NPI 1679774582
$5,673.20
in general payments reported to CMS, 2019-2025
37 companies · $499 in 2025
The $499 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $971 · 2020: $625 · 2021: $1,148 · 2022: $811 · 2023: $1,048 · 2024: $571 · 2025: $499.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,118.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,117.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $636.42 | 2019-2025 | Arexvy, Bexsero, Shingrix |
| Pfizer INC. | $506.94 | 2019-2025 | |
| Astrazeneca Pharmaceuticals LP | $497.61 | 2019-2025 | Breztri, Airsupra, Farxiga |
| Novo Nordisk INC | $466.10 | 2019-2025 | Rybelsus, Ozempic |
| Dexcom, INC. | $402.60 | 2022-2025 | Dexcom G7 Gss (161), Dexcom G6 Transmitter |
| Boehringer Ingelheim Pharmaceuticals, INC. | $243.73 | 2019-2024 | Jardiance |
| Lilly USA, LLC | $237.73 | 2019-2025 | Mounjaro, Zepbound, Jardiance |
| Novartis Pharmaceuticals Corporation | $220.40 | 2019 | |
| Merck Sharp & Dohme LLC | $205.68 | 2019-2024 | Gardasil, Capvaxive, Gardasil 9 |
| Abbvie INC. | $205.48 | 2021-2023 | |
| Exact Sciences Corporation | $184.95 | 2023-2025 | Cologuard Collection Kit |
| Allergan, INC. | $175.99 | 2019-2020 | |
| Genentech USA, INC. | $151.38 | 2020-2021 | |
| Edwards Lifesciences Corporation | $141.63 | 2023 | Sapien 3 Ultra Resilia |
| Teva Pharmaceuticals USA, INC. | $140.30 | 2019 |
Show all 37 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Beau Ellenbecker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.